[PDF][PDF] SNMMI procedure standard/EANM practice guideline for nuclear medicine evaluation and therapy of differentiated thyroid cancer: abbreviated version

AM Avram, L Giovanella, B Greenspan, SA Lawson… - 2022 - Soc Nuclear Med
Editor's note: SNMMI and the European Association of Nuclear Medicine periodically define
new standards/guidelines for nuclear medicine practice to help advance the science of …

Management of differentiated thyroid cancer: The standard of care

AM Avram, K Zukotynski, HR Nadel… - Journal of nuclear …, 2022 - Soc Nuclear Med
In the past decade, the management of differentiated thyroid cancer (DTC) underwent a
paradigm shift toward the use of risk stratification with the goal of maximizing the benefit and …

Delay of initial radioactive iodine therapy beyond 3 months has no effect on clinical responses and overall survival in patients with thyroid carcinoma: A cohort study …

F Cheng, J Xiao, F Huang, C Shao, S Ding… - Cancer …, 2022 - Wiley Online Library
Background More than a third of thyroid carcinoma (TC) patients require treatment with
radioactive iodine (RAI), but the timing of initial RAI therapy after thyroidectomy remains …

Is a four-week hormone suspension necessary for thyroid remnant ablation in low and intermediate risk patients? A pilot study with quality-of-life assessment

PAL Santos, MEDM Flamini, FA Mourato… - Brazilian Journal of …, 2022 - bjrs.org.br
Radioiodine therapy (RIT) is a complementary treatment to total thyroidectomy in
differentiated thyroid cancer (DTC) patients. High levels of thyroid-stimulating hormone …

Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma

H Samimi, V Haghpanah - Cancer Cell International, 2022 - Springer
Radioiodine (RAI) is the mainstay of treatment for differentiated thyroid carcinoma (DTC)
following total thyroidectomy. Nevertheless, about 5% of patients with DTC are RAI …

[PDF][PDF] 目前对分化型甲状腺癌患者放射性碘治疗准备工作主要方面的看法: 文献综述

MV Reinberg, KY Slashchuk, AA Trukhin… - Digital …, 2023 - jdigitaldiagnostics.com
АННОТАЦИЯ Рак щитовидной железы—наиболее распространённая опухоль
эндокринной системы, составляющая 1–3% всех злокачественных новообразований …

Radioiodine Theranostics of Differentiated Thyroid Carcinoma

AM Avram - Integrated Diagnostics and Theranostics of Thyroid …, 2023 - Springer
Current management of patients with thyroid cancer requires a risk-adapted approach to
treatment and multidisciplinary cooperation. Routine use of 131-I administration after total …

Preparation for radioiodine therapy in patients with differentiated thyroid cancer, modern perspective. Review of the literature.

MV Ryzhenko, KY Slashchuk, AA Trukhin… - Digital …, 2023 - jdigitaldiagnostics.com
Thyroid cancer is the most common tumor of the endocrine system, 1-3% of all malignant
neoplasms as of 2021. Differentiated forms, papillary and follicular, with a relatively …

[PDF][PDF] JNM Editors' Choice Awards for 2021

J Czernin - J Nucl Med, 2021 - Soc Nuclear Med
Editor's note: SNMMI and the European Association of Nuclear Medicine periodically define
new standards/guidelines for nuclear medicine practice to help advance the science of …

[引用][C] Preparation for radioiodine therapy in patients with differentiated thyroid cancer: a modern perspective (a review)

MV Reinberg, KY Slashchuk, AA Trukhin… - Digital …, 2023 - jdigitaldiagnostics.com